Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine
Home of the Shanghai APL Protocol β Ruijin Hospital leads in hematological cancers, CAR-T therapy, proton therapy, and complex gastrointestinal and pancreatic surgery.
About Ruijin Hospital, Shanghai
Ruijin Hospital, formally known as Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, is a Grade III Class A large general teaching hospital founded in Shanghai in 1907 β originally under the name Guangci Hospital. The hospital operates across three campuses: Huangpu (main), Jiading, and Yuanyang, with 2,442 approved beds and a comprehensive range of medical specialties including oncology, hematology, surgery, radiation oncology, and nuclear medicine.
Ruijin Hospital has a globally recognised history in hematology. Its team developed the all-trans retinoic acid and arsenic trioxide combination therapy for acute promyelocytic leukemia β the 'Shanghai Protocol' β a landmark advance that transformed APL from a high-mortality into a largely curable disease. Today, its hematology department maintains dedicated specialist clinics for CAR-T therapy and lymphoma autologous stem-cell transplantation, and has published active research on BCMA-directed CAR-T for multiple myeloma and CAR-T pathways for large B-cell lymphoma.
The hospital's oncology department focuses on gastrointestinal cancers β gastric, colorectal, and pancreatic β and integrates systemic therapy, targeted treatment, precision oncology, and cellular immunotherapy. Its radiation oncology service spans advanced photon techniques (IGRT, IMRT, VMAT, SBRT, tomotherapy) and is complemented by the Ruijin Hospital Tumor Proton Center in Jiading, which treated 600 patients across nearly 50 tumour types in its first 18 months of clinical operation.
For international patients, CancerFax reviews medical reports and routes cases to the appropriate Ruijin Hospital department β hematology for CAR-T or transplant evaluation, oncology for gastrointestinal or pancreatic cancer, or radiation oncology for proton-therapy assessment. We coordinate hospital communication, appointment scheduling, interpreter support, and continuity of follow-up after patients return home.
| Hospital at a Glance | |
|---|---|
| Country | China |
| City | Shanghai |
| Established | 1907 |
| Hospital Type | Grade III Class A General Teaching Hospital |
| Affiliation | Shanghai Jiao Tong University School of Medicine |
| Beds | 2,442 approved beds |
| Proton Therapy | Tumor Proton Center, Jiading District (opened Nov 2023) |
| Research Focus | Hematology, CAR-T, APL, gastrointestinal oncology, pancreatic surgery, proton therapy |
Why Patients Choose This Hospital
Cancer Specialties and Clinical Departments
Advanced Treatment Capabilities
Our Medical Specialists
Ruijin Hospital's oncology-related specialties are led by senior physicians with national and international recognition. Key clinical leaders include Prof. Zhang Jun (Director, Oncology β gastrointestinal and precision oncology), Prof. Chen Jiayi (Director, Radiation Oncology β breast radiotherapy, proton vs photon research), Prof. Zhao Weili (Hematology β lymphoma, CAR-T pathways), and Prof. Shen Baiyong (General Surgery and Pancreatic Center β pancreatic surgery and translational research).
Appointment availability, current administrative titles, and suitability for a specific case should be confirmed by CancerFax before consultation is arranged. The hospital designates the treating physician based on diagnosis and department assessment.
Patients seeking specific physician consultations or second opinions may request a review through the CancerFax coordination process before confirming travel or admission.
World-Class Infrastructure
- Proton Therapy β domestically developed system at Tumor Proton Center, Jiading District
- Image-Guided Radiotherapy (IGRT) and Intensity-Modulated Radiotherapy (IMRT)
- Volumetric-Modulated Arc Therapy (VMAT) and Stereotactic Body Radiotherapy (SBRT)
- Tomotherapy, 3D brachytherapy, and respiratory-motion management
- Dedicated CAR-T specialist clinic β lymphoma and multiple myeloma pathways
- Lymphoma autologous stem-cell transplantation specialist clinic
- Allogeneic hematopoietic stem-cell transplantation pathways
- BCMA-directed CAR-T research programme
- PET/MR combined imaging for staging and treatment planning
- PET/CT and SPECT/CT imaging systems
- Radionuclide treatment ward for selected thyroid and neuroendocrine cases
- Digital pathology initiatives and tumour-pathology expertise
- Robotic minimally invasive pancreatic surgery through dedicated Pancreatic Center
- Hepatobiliary, gastrointestinal, thoracic, and gynaecological surgical pathways
- Radiological interventional oncology research in combination with immunotherapy
- Multidisciplinary tumour boards for gastrointestinal and pancreatic cancers
Services for International Patients
What to Prepare Before Traveling
- arrow_rightConfirm appointment campus β main campus (Huangpu) or Tumor Proton Center (Jiading) β before booking accommodation
- arrow_rightPrepare pathology reports, imaging (with DICOM files), treatment history, blood tests, and molecular reports before submission
- arrow_rightFor CAR-T evaluation: include bone marrow biopsy, flow cytometry, antigen expression (CD19, CD22, BCMA), and complete prior treatment lines
International Medical Department contact: Tel 021-6467-8970 / Email [email protected]. Services beyond English-language support (interpreter languages, visa documents, teleconsultation) should be confirmed before travel.
Patient Amenities & Facilities
Family accommodation near Ruijin Hospital's Huangpu campus is available in the surrounding Huangpu district. CancerFax can help with practical arrangements for accompanying family members.
How to Reach This Hospital
How CancerFax Helps
CancerFax is a specialist cancer access and patient-navigation platform. We help patients and families understand their options, organise medical records, coordinate hospital communication, and support cross-border treatment planning where appropriate.
We help collect and organise reports, scans, pathology, biomarker results, and treatment history for structured case review.
We communicate with hospitals or trial teams to assess whether a case may be suitable for further screening.
We support appointment coordination, document submission, translation, and direct communication with international departments.
For international patients, we help with practical coordination β travel planning, hospital admission guidance, and local support.
If this option is not suitable, we help explore other relevant treatments, clinical trials, or advanced care pathways.
From inquiry through to follow-up, our coordinators provide a single point of contact for the family.
CancerFax does not guarantee treatment access, eligibility, or clinical outcome. Our role is to help patients access accurate information, structured review, and appropriate specialist pathways.
Patient Questions Answered
CancerFax supports international patients through every stage of accessing Ruijin Hospital. We begin by reviewing your medical reports β diagnosis, pathology, imaging, treatment history, and relevant molecular tests β to identify which Ruijin Hospital department is most appropriate: hematology for CAR-T or transplant evaluation, oncology for gastrointestinal or pancreatic cancer, or radiation oncology for proton-therapy review.
Once we understand your case, we prepare a structured summary and submit it to the relevant Ruijin Hospital team. We then coordinate the hospital's response, clarify any additional tests they need, and help you understand the preliminary treatment guidance they provide. After the hospital confirms an appointment or admission pathway, CancerFax helps with practical planning β interpreter arrangements, travel coordination, accommodation near the relevant campus, and continuity of follow-up with your local oncologist after you return home.
Ruijin Hospital's hematology department operates a dedicated CAR-T specialist clinic with published treatment pathways for lymphoma and multiple myeloma, including BCMA-directed research. Whether an international patient can access CAR-T at Ruijin Hospital depends on diagnosis, antigen expression, prior treatment history, organ function, disease status, and the specific product or protocol. CancerFax reviews your hematology reports and coordinates eligibility confirmation with the hospital before any travel is arranged.
Yes. Ruijin Hospital operates a Tumor Proton Center in Jiading District using a domestically developed proton therapy system. The centre had treated 600 patients across nearly 50 tumour types in its first 18 months of clinical operation. Proton therapy is not appropriate for every tumour β a radiation oncologist must review your tumour location, pathology, prior radiation history, and treatment objectives. CancerFax can coordinate proton-therapy eligibility assessment with the Ruijin radiation oncology team.
For most solid tumour cases, prepare a medical summary, pathology and biopsy report, recent imaging reports with DICOM files, blood tests, treatment history, and any NGS or molecular reports. For blood cancer and CAR-T evaluation, also include bone marrow aspiration and biopsy, flow cytometry with antigen expression results (CD19, CD22, BCMA as relevant), FISH cytogenetics, and a complete history of all prior treatment lines. CancerFax will identify any missing documents before submitting the case to the hospital.
No. Ruijin Hospital's main campus is in Huangpu District (No. 197 Ruijin Road Number Two). The Tumor Proton Center is at a separate location in Jiading District (No. 889 Shuangding Road). If your treatment plan involves both departments β for example, hematology at the main campus and proton-therapy evaluation in Jiading β you should plan accommodation and transport accordingly. CancerFax helps patients plan practically for the relevant campus.
Send Your Medical Reports to Ruijin Hospital via CancerFax
Ruijin Hospital offers CAR-T therapy, proton therapy, stem-cell transplantation, and expert gastrointestinal and pancreatic cancer surgery. Share your medical reports with CancerFax for a structured review and hospital routing.